UNSPSC 51473301: Bibrocathol

This classification denotes an antimicrobial with the molecular formula C6Br4O2.Bi.HO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0KJ20H1BLJ, chemically known as 4,5,6,7-tetrabrom-1,3,2-benzodioxabismol-2-ol but generally known as bibrocathol, which bears US NIH Compound Identifier 16683103. European Medicines Agency schedules Bibrocathol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05816MIG. The term BIBROCATHOL is an International Non-Proprietary Name.

UNSPSC 51473301 Bibrocathol, a Commodity code, covers pharmaceutical and medical supply procurement by state and local government agencies, though recent solicitations show the code being applied to broader janitorial and consumable supplies for public safety operations. State and local governments procure under this code as part of cooperative purchasing agreements and direct county procurement for operational consumables. The work encompasses both pharmaceutical products sold through multi-state cooperative agreements and consumable supplies delivered on an as-needed basis to government facilities operating continuous operations. Issuing bodies include county boards of commissioners managing fire and public safety operations, and state-level cooperative purchasing alliances administering multi-jurisdictional pharmaceutical and OTC product agreements that serve participating state agencies and local government customers across multiple states.

Recent activity shows geographically dispersed procurement. Hillsborough County Board of County Commissioners in Florida posted ITB 26-00319 for consumable janitorial and operational supplies due July 24, 2026, with an estimated contract value of $765,679.84 for one year, targeted at supplying 47 fire stations operating 24/7; delivery to the Public Safety Operations Complex in Tampa, Florida is required within 10 days of purchase order receipt with Friday scheduling restrictions. The Minnesota Department of Administration's Office of State Procurement, administering the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), issued RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products due March 26, 2026, serving participating state and local government facilities across Minnesota and Oregon, with contract effectiveness scheduled for July 1, 2026. The MMCAP solicitation requires vendors to meet cGMP and Drug Supply Chain Security Act compliance, maintain relationships with authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health, and Morris & Dickson Co.), and submit detailed product information by National Drug Code; scoring weights 75 percent on price competitiveness and 25 percent combined on fixed pricing, administrative compliance, EDI capability, and administrative fee agreement.